SS Innovations International, Inc.

SS Innovations International, Inc. is a medical technology company dedicated to developing advanced, affordable, and accessible robotic surgical systems. Founded by Dr. Sudhir Srivastava, a renowned robotic cardiac surgeon, the company's mission is to expand access to advanced surgical care globally, particularly in underserved populations. While its R&D headquarters are in Gurugram, Haryana, India, the company's principal executive offices are located in Fort Lauderdale, Florida, USA.

The company's primary product is the SSi Mantra surgical robotic system, designed for multi-specialty soft-tissue surgeries, including cardiac, urology, gynecology, general surgery, thoracic, head & neck, colorectal, and gastroenterology procedures. SS Innovations also offers a suite of surgical instruments under the SSi Mudra brand and is involved in mixed reality training and multimedia recording technologies. The SSi Mantra system is distinguished by its modular design, superior ergonomics, and cost-effectiveness, aiming to provide a more affordable alternative to existing robotic surgery platforms.

Led by Dr. Sudhir Srivastava as Chairman and CEO, and with Dr. Frederic Moll (co-founder of Intuitive Surgical) serving as Vice Chairman, SS Innovations has been actively expanding its global footprint. In March 2026, the company raised $18.6 million in a private placement to support its global expansion. As of December 2025, over 168 SSi Mantra systems had been installed worldwide, with approximately 7,885 procedures performed. The company filed for 510(k) clearance with the FDA in December 2025, anticipating approval by mid-2026, and expects to secure EU CE mark certification in 2026, positioning itself for significant growth in the U.S. and European markets.